Prediction Markets Face Growing State and Federal Regulatory Clash 16 States in Legal Proceedings One Bans Platforms World Bank Data Suggests Automation Poses Significant Job Risks in India China and Ethiopia Wall Street Hits New Peaks Nasdaq and Micron Set Records United Airlines Taps Starlink Q4 Earnings Season Shows Mixed Results Across Key Sectors Coastal Erosion Threatens UK Property Values and Infrastructure Spending The Slapton Line Case Kevin Warshs Potential Fed Regime Change Could Reshape Wall Streets Market Plumbing Littelfuse LFUS Q1 2026 Earnings Earnings Beat Driven by Operational Discipline and Demand Resilience PHAR Q1 2026 Earnings EPS Misses Estimates by Wide Margin GTM Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher L3Harris Technologies Q1 2026 Earnings EPS Beats Estimates by 591 Stock Rises AutoNation Q1 2026 Earnings EPS Beats Estimates Amid Stable Demand FFAI Q1 2026 Earnings EPS Surprises by Nearly 70 but Stock Sinks Amid Missing Revenue Princeton Bancorp BPRN Nears Resistance Amid Quiet Trading What to Watch Smurfit WestRock SW Gains 15 as Packaging Sector Shows Resilience Key Levels in Focus Revolve Group RVLV Gains 423 as Bullish Momentum Builds Vontier Corporation VNT Gains 246 as Industrial Sector Finds Footing Cerence Inc CRNC Gains 328 Testing Resistance Near 12 Fed Rate Hike Expectations Resurface as Inflation Surge Reshapes Market Sentiment EPAC Q1 2026 Earnings EPS Falls Slightly Short of Estimates Shares Edge Higher US Global Investors GROW Edges Lower as Stock Nears Key Support Zone SoFi Q1 2026 Earnings EPS Falls Just Shy of Estimates Stock Declines BIVI Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Drops General Mills Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Persist Transdigm Group TDG Q1 2026 Earnings EPS Surpasses Estimates as Core Markets Remain Strong BRN Q4 2024 Earnings Loss Reported Amid Challenging Energy Environment ZW Data Action Technologies Inc CNET Q3 2011 Earnings Sharp EPS Miss as Stock Stages Surprise Gain ELDN Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates Amid Ongoing Development Costs